Lorajmine

Lorajmine
Systematic (IUPAC) name
	(17R,21β)-ajmalan-17,21-diol 17-chloroacetate; OR; (1R,9R,10S,13R,14R,16S,18S)-13-ethyl-8-methyl-14-hydroxy-8,15-diazahexacyclo [14.2.1.01,9.02,7.010,15.012,17]nonadeca-2(7),3,5-triene-18-yl chloroacetate
Identifiers
CAS Number	47562-08-3
ATC code	C01BA12 (WHO)
PubChem	CID: 76957773
ChemSpider	16735878
UNII	F96VX65849
ChEMBL	CHEMBL2111031
Chemical data
Formula	C22H27ClN2O3
Molecular mass	402.914 g/mol
	SMILES CCC1C2CC3C4C5(CC(C2C5C(=O)OCCl)N3C1O)C6=CC=CC=C6N4C ;
	InChI InChI=1S/C22H27ClN2O3/c1-3-11-12-8-15-19-22(13-6-4-5-7-14(13)24(19)2)9-16(25(15)21(11)27)18(12)20(22)28-17(26)10-23/h4-7,11-12,15-16,18-21,27H,3,8-10H2,1-2H3/t11-,12-,15-,16-,18?,19-,20+,21+,22+/m0/s1 ; Key:LAHDERDHXJFFJU-KBFYUGGWSA-N ;
(verify)

Lorajmine (17-monochloroacetylajmaline) is a drug that is a potent sodium channel blocker (more specifically, a class Ia antiarrhythmic agent) that was used for treating arrhythmia.^[1]^[2] It is derived from ajmaline, an alkaloid from the roots of Rauwolfia serpentina, by synthetically adding a chloroacetate residue.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.